Jean-Paul Mazaleyrate

Title: Jean-Paul Mazaleyrate: Innovator in Cyclopeptide Derivatives

Introduction

Jean-Paul Mazaleyrate is a notable inventor based in Choisy-Le-Roi, France. He has made significant contributions to the field of biochemistry, particularly in the development of cyclopeptide derivatives. His work focuses on creating selective inhibitors that can be utilized in various therapeutic applications.

Latest Patents

Mazaleyrate holds a patent for cyclopeptide derivatives that serve as protease inhibitors. The invention relates to a specific formula where R¹ is a halogen atom, such as bromine, or a radical, while R² can be a hydrogen atom, an alkyl radical, or other groups. R³ is defined as NH, O, or S, and Z comprises a peptide sequence along with a group that connects to the aromatic nucleus. This innovative approach has the potential to impact the treatment of diseases that involve protease activity. He has 1 patent to his name.

Career Highlights

Mazaleyrate is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work there has allowed him to explore various aspects of peptide chemistry and its applications in medicine. His research has contributed to a deeper understanding of protease inhibitors and their potential uses.

Collaborations

Throughout his career, Mazaleyrate has collaborated with esteemed colleagues such as Michel Wakselman and Michele Reboud-Ravaux. These partnerships have enriched his research and expanded the scope of his innovations.

Conclusion

Jean-Paul Mazaleyrate is a prominent figure in the field of biochemistry, particularly known for his work on cyclopeptide derivatives. His contributions to the development of selective protease inhibitors highlight the importance of innovation in medical research. His ongoing work continues to inspire advancements in therapeutic applications.